erlotinib hydrochloride has been researched along with gastrin-releasing peptide in 1 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (gastrin-releasing peptide) | Trials (gastrin-releasing peptide) | Recent Studies (post-2010) (gastrin-releasing peptide) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 1,392 | 18 | 252 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, H; Grandis, JR; Lui, VW; Mills, GB; Siegfried, JM; Smithgall, TE; Thomas, SM; Xi, S; Zhang, Q | 1 |
1 other study(ies) available for erlotinib hydrochloride and gastrin-releasing peptide
Article | Year |
---|---|
Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; ADAM Proteins; ADAM17 Protein; Amphiregulin; Antineoplastic Agents; Cell Line; CSK Tyrosine-Protein Kinase; EGF Family of Proteins; ErbB Receptors; Erlotinib Hydrochloride; Gastrin-Releasing Peptide; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Quinazolines; Recombinant Fusion Proteins; Signal Transduction; src-Family Kinases; Tumor Necrosis Factor-alpha | 2006 |